374 related articles for article (PubMed ID: 10484286)
1. L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
ThyagaRajan S; Quadri SK
Endocrine; 1999 Jun; 10(3):225-32. PubMed ID: 10484286
[TBL] [Abstract][Full Text] [Related]
2. Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats.
Thyagarajan S; Meites J; Quadri SK
Endocrinology; 1995 Mar; 136(3):1103-10. PubMed ID: 7867565
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors.
ThyagaRajan S; Felten SY; Felten DL
Cancer Lett; 1998 Jan; 123(2):177-83. PubMed ID: 9489486
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumors.
ThyagaRajan S; Madden KS; Stevens SY; Felten DL
J Neuroimmunol; 2000 Sep; 109(2):95-104. PubMed ID: 10996211
[TBL] [Abstract][Full Text] [Related]
5. Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after L-deprenyl treatment.
ThyagaRajan S; Stevens SY; Felten DL
Brain Res Bull; 1999 Mar; 48(5):513-20. PubMed ID: 10372512
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor growth by L-deprenyl involves neural-immune interactions in rats with spontaneously developing mammary tumors.
Thyagarajan S; Madden KS; Stevens SY; Felten DL
Anticancer Res; 1999; 19(6B):5023-8. PubMed ID: 10697505
[TBL] [Abstract][Full Text] [Related]
7. Deprenyl stimulates the efflux of monoamines from the rat hypothalamus in vitro.
MohanKumar PS; MohanKumar SM; Quadri SK
Brain Res Bull; 2001 Apr; 54(6):675-80. PubMed ID: 11403995
[TBL] [Abstract][Full Text] [Related]
8. L-Deprenyl stimulates the release of catecholamines in the rat medial basal hypothalamus in vivo.
ThyagaRajan S; Quadri SK
Neurosci Lett; 1999 Jul; 270(2):79-82. PubMed ID: 10462102
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
10. Changes in mediobasal hypothalamic dopamine and indoleamine metabolism after superior cervical ganglionectomy of rats.
Esquifino AI; Arce A; Muñoz RM; Villanúa MA; Cardinali DP
J Neural Transm (Vienna); 1996; 103(3):287-98. PubMed ID: 8739840
[TBL] [Abstract][Full Text] [Related]
11. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
12. Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Gupta M; Wiener HL
Neurochem Res; 1995 Apr; 20(4):385-9. PubMed ID: 7544444
[TBL] [Abstract][Full Text] [Related]
13. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
14. The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts.
Fogel WA; Andrzejewski W; Sasiak K; Maslinski C
Inflamm Res; 2000 Apr; 49 Suppl 1():S45-6. PubMed ID: 10864416
[No Abstract] [Full Text] [Related]
15. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
Kumagae Y; Matsui Y; Iwata N
Jpn J Pharmacol; 1991 Jan; 55(1):121-8. PubMed ID: 1904113
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
17. Deprenyl reduces serum prolactin concentrations in rats.
MohanKumar PS; Meites J; Quadri SK
Life Sci; 1994; 54(13):841-5. PubMed ID: 8139373
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
Bondiolotti GP; Galva MD; Villa F; Sciaba L; Picotti GB
Biochem Pharmacol; 1995 Jun; 50(1):97-102. PubMed ID: 7605351
[TBL] [Abstract][Full Text] [Related]
19. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
Sivam SP
Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.
Paterson IA; Davis BA; Durden DA; Juorio AV; Yu PH; Ivy G; Milgram W; Mendonca A; Wu P; Boulton AA
Neurochem Res; 1995 Dec; 20(12):1503-10. PubMed ID: 8789614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
